Benzinga

Benzinga

Benzinga

venerdì, agosto 28

Surgepays Inc

SURGNASDAQ
Trade with Public
Trade with Public
$0.1761
0.00191.09%
In chiusura: Aug 27, 5:00 PM EST
$0.1730
-0.0031-1.76%
Post-mercato: 7:59 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Surgepays Analyst Price Targets

Wall Street analyst price targets and consensus rating for Surgepays (SURG).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

1Buy
1Hold
Consensus RatingBuy# Analysts2Avg. Consensus PT$4Upside to Avg. PT+1923.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jun 10, 2026Ascendiant CapitalEdward WooPT CutBuy$5→$4
Apr 17, 2026Ascendiant CapitalEdward WooPT CutBuy$10→$5
More with Benzinga EdgeGet Access

Analyst Ratings News

Micron Technology To $900? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts change outlook on top names, including upgrades/downgrades. Check our analyst ratings page for complete view.
Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on Surgepays, Lowers Price Target to $3.5

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and lowers the price target from $5 to $3.5.
Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Surgepays, Lowers Price Target to $5

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and lowers the price target from $9.75 to $5.
Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Surgepays, Raises Price Target to $9.75

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and raises the price target from $9.5 to $9.75.
Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Surgepays, Raises Price Target to $9.5

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and raises the price target from $9 to $9.5.
Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Surgepays, Raises Price Target to $9

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and raises the price target from $8.75 to $9.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved